Insmed Incorporated (INSM) Stock Price Today—Real Time Charts and Quotes

Q: What's the stock price of Insmed Incorporated (INSM) today?

Insmed Incorporated (INSM) is currently trading at $143.84, with a 24h change of +0.69%. The 52-week trading range is $142.05–$166.88.

Q: What are the 52-week high and low prices for Insmed Incorporated (INSM)?

INSM has a 52-week high of $166.88 and a 52-week low of $142.05, with the current price at $143.84.

Q: What is the price-to-earnings (P/E) ratio of Insmed Incorporated (INSM)? What does it indicate?

The current P/E ratio (TTM) of INSM is -29.121327939535156, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Biotechnology industry for a better context.

Q: What is the market cap of Insmed Incorporated (INSM)?

Insmed Incorporated (INSM) currently has a market cap of approximately $30.77B.

Q: What is the most recent quarterly earnings per share (EPS) for Insmed Incorporated (INSM)?

Insmed Incorporated (INSM)'s diluted earnings per share (Diluted EPS) is -5.976375815050764. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Insmed Incorporated (INSM) now?

As of now, INSM is trading at $143.84, with a P/E ratio of -29.121327939535156 and a diluted EPS of -5.976375815050764. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Insmed Incorporated's financial reports, the outlook of the Biotechnology sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Insmed Incorporated (INSM)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Biotechnology sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Insmed Incorporated (INSM) stock?

You can buy Insmed Incorporated (INSM) through Gate. Sign up for a Gate account and complete identity verification, then go to the Insmed Incorporated trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$143,84

+$0,99(+0,69%)

*Data last updated: 2026-04-17 18:43 (UTC+8)

As of 2026-04-17 18:43, Insmed Incorporated (INSM) is priced at $143,84, with a total market cap of $30,77B, a P/E ratio of -29,12, and a dividend yield of 0,00%. Today, the stock price fluctuated between $142,30 and $145,55. The current price is 1,08% above the day's low and 1,17% below the day's high, with a trading volume of 2,14M. Over the past 52 weeks, INSM has traded between $142,05 to $166,88, and the current price is -13,80% away from the 52-week high.

INSM Key Stats

Yesterday's Close$146,74

Market Cap$30,77B

Volume2,14M

P/E Ratio-29,12

Dividend Yield (TTM)0,00%

Diluted EPS (TTM)5,98

Net Income (FY)-$1,27B

Revenue (FY)$606,42M

Earnings Date2026-05-14

EPS Estimate0,97

Revenue Estimate$301,56M

Shares Outstanding209,74M

Beta (1Y)1.101

About INSM

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

SectorHealthcare

IndustryBiotechnology

CEOWilliam H. Lewis

HeadquartersBridgewater,NJ,US

Official Websitehttps://www.insmed.com

Employees (FY)1,66K

Average Revenue (1Y)$364,43K

Net Income per Employee-$767,29K

Insmed Incorporated (INSM) FAQ

What's the stock price of Insmed Incorporated (INSM) today?

Insmed Incorporated (INSM) is currently trading at $143,84, with a 24h change of +0,69%. The 52-week trading range is $142,05–$166,88.

What are the 52-week high and low prices for Insmed Incorporated (INSM)?

What is the price-to-earnings (P/E) ratio of Insmed Incorporated (INSM)? What does it indicate?

What is the market cap of Insmed Incorporated (INSM)?

What is the most recent quarterly earnings per share (EPS) for Insmed Incorporated (INSM)?

Should you buy or sell Insmed Incorporated (INSM) now?

What factors can affect the stock price of Insmed Incorporated (INSM)?

How to buy Insmed Incorporated (INSM) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.